1. C. M. Metzler. Bioavailability—A problem in equivalence,Biometrics 30:309–317 (1974).
2. W. J. Westlake. Use of statistical methods in evaluation ofin vivo performance of dosage forms,J. Pharm. Sci. 62:1579–1589 (1973).
3. R. Snyder, S. L. Longacre, D. Sammett, C. M. Witner, and J. J. Kocsis. Relationship between the toxicity and metabolism of benzene, In M. Mehlman (ed.),Carcinogenicity and Toxicity of Benzene, Princeton Scientific Publishers, Princeton, NJ, 1983.
4. J. D. Sun, R. F. Henderson, T. C. Marshall, Y. Cheng, J. S. Dutcher, J. A. Pickrell, J. L. Mauderly, F. F. Hahn, D. A. Banas, F. A. Seiler, and C. H. Hobbs. The inhalation toxicity of two commercial dyes: Solvent yellow 33 and solvent green 3,Fund. Appl. Toxicol. 8:358–371 (1987).
5. R. L. Burden, J. D. Faires, and A. C. Reynolds.Numerical Analysis, Prindle, Weber, & Schmidt, Boston, MA, 1978, chap. 5.